PL2785701T3 - Krystaliczna postać kabazytakselu i sposób jej otrzymywania - Google Patents

Krystaliczna postać kabazytakselu i sposób jej otrzymywania

Info

Publication number
PL2785701T3
PL2785701T3 PL12809858T PL12809858T PL2785701T3 PL 2785701 T3 PL2785701 T3 PL 2785701T3 PL 12809858 T PL12809858 T PL 12809858T PL 12809858 T PL12809858 T PL 12809858T PL 2785701 T3 PL2785701 T3 PL 2785701T3
Authority
PL
Poland
Prior art keywords
carbazitaxel
preparation
crystalline form
crystalline
Prior art date
Application number
PL12809858T
Other languages
English (en)
Inventor
Saswata Lahiri
Rajesh Srivastava
Bhuwan Bhaskar MISHRA
Shatrughan SHARMA
Vijay Ojha
Nilendu Panda
Sandeep Kumar
Sonu PRASAD
Original Assignee
Fresenius Kabi Oncology Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47501388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2785701(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi Oncology Limited filed Critical Fresenius Kabi Oncology Limited
Publication of PL2785701T3 publication Critical patent/PL2785701T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
PL12809858T 2011-11-28 2012-11-19 Krystaliczna postać kabazytakselu i sposób jej otrzymywania PL2785701T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3405DE2011 2011-11-28
PCT/IN2012/000752 WO2013080217A2 (en) 2011-11-28 2012-11-19 Crystalline forms of carbazitaxel and process for preparation thereof
EP12809858.9A EP2785701B1 (en) 2011-11-28 2012-11-19 Crystalline form of carbazitaxel and process for preparation thereof

Publications (1)

Publication Number Publication Date
PL2785701T3 true PL2785701T3 (pl) 2019-08-30

Family

ID=47501388

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12809858T PL2785701T3 (pl) 2011-11-28 2012-11-19 Krystaliczna postać kabazytakselu i sposób jej otrzymywania

Country Status (7)

Country Link
US (1) US8901322B2 (pl)
EP (1) EP2785701B1 (pl)
CN (1) CN104011035A (pl)
DE (1) DE112012004944T5 (pl)
ES (1) ES2716799T3 (pl)
PL (1) PL2785701T3 (pl)
WO (1) WO2013080217A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
EP2791122B1 (en) 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
US9394266B2 (en) 2012-03-08 2016-07-19 IVAX International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
CN102746258B (zh) * 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
CN103819428B (zh) * 2012-11-19 2016-01-13 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇的溶剂化物的晶型及其制备方法
CN103333138A (zh) * 2013-07-22 2013-10-02 北京科莱博医药开发有限责任公司 卡巴他赛新晶型、其制备方法、其用途及药物组合物
US20150141673A1 (en) * 2013-11-15 2015-05-21 Honghai SONG Novel crystalline for w of cabazitaxel and method for preparing it
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
AU2017207821A1 (en) 2016-01-15 2018-07-19 Zhuhai Beihai Biotech Co., Ltd. Compositions and formulations including cabazitaxel and human serum albumin
CN112055588B (zh) 2018-04-20 2023-09-08 珠海贝海生物技术有限公司 卡巴他赛的制剂和组合物
US12161990B2 (en) * 2018-12-11 2024-12-10 ExxonMobil Technology and Engineering Company EMM-41 composition, methods of making and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5475120A (en) * 1990-11-02 1995-12-12 University Of Florida Method for the isolation and purification of taxol and its natural analogues
US5847170A (en) 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation

Also Published As

Publication number Publication date
CN104011035A (zh) 2014-08-27
ES2716799T3 (es) 2019-06-17
DE112012004944T5 (de) 2014-12-11
US8901322B2 (en) 2014-12-02
WO2013080217A4 (en) 2013-09-19
EP2785701B1 (en) 2019-01-02
WO2013080217A3 (en) 2013-07-25
US20130211109A1 (en) 2013-08-15
EP2785701A2 (en) 2014-10-08
WO2013080217A2 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
PL2609120T3 (pl) Ulepszony sposób wytwarzania sugammadeksu
PL2785701T3 (pl) Krystaliczna postać kabazytakselu i sposób jej otrzymywania
IL246265B (en) A method for the production of intermediates for the preparation of 5-fluoro-h1-pyrazolopyridines and such compounds
IL227333B (en) A method for preparing glycosphingolipids and their uses
ZA201305972B (en) Method for the preparation of biphephos
PL2734536T3 (pl) Sposób wytwarzania estetrolu
EP2747975A4 (en) MANUFACTURED ARTICLE AND PROCESS FOR PREPARING THE SAME
SG11201400939YA (en) Process for the preparation of methoxymelonal
EP2736905A4 (en) INTERMEDIATE COMPOUNDS AND PROCESS FOR THE PREPARATION OF LURASIDONE AND SALTS THEREOF
EP2663568A4 (en) PROCESS FOR THE PREPARATION OF ACETALS
ZA201302020B (en) Process for preparation of rilpivirine intermediate
ZA201403736B (en) Process for the preparation of sterol derivatives
SG2014010441A (en) Preparation process of l-methionine
EP2691385A4 (en) IMPROVED METHOD FOR THE PRODUCTION OF IMATINIB AND ITS MESYLATE SALT
IL232424A (en) Process for the preparation of 1-noble-4-phenylsulfonylprolinamide and intermediates
IL231505B (en) Pharmaceutical preparation and method for its production
ZA201305277B (en) Phenyl-isoxazol derivatives and preparation process thereof
SI3309158T1 (sl) Rivaroksaban kristalne oblike K in postopek njegove priprave
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
IL230977A (en) A crystalline form of relapaldib
IL226329A0 (en) A method @ for preparation @ from a tax salon
IL218764A0 (en) Crystalline levofolinic acid and process for its preparation
EP2537851A4 (en) PROCESS FOR PREPARING B-GLYCOSIDE COMPOUNDS
PL2739605T3 (pl) Sposób wytwarzania postaci krystalicznej I agomelatyny
ZA201309732B (en) Process for the preparation of dexlansoprazole